PL1791601T3 - Nowa szczepionka przeciwgrzybicza i sposób jej wytwarzania - Google Patents

Nowa szczepionka przeciwgrzybicza i sposób jej wytwarzania

Info

Publication number
PL1791601T3
PL1791601T3 PL05786111T PL05786111T PL1791601T3 PL 1791601 T3 PL1791601 T3 PL 1791601T3 PL 05786111 T PL05786111 T PL 05786111T PL 05786111 T PL05786111 T PL 05786111T PL 1791601 T3 PL1791601 T3 PL 1791601T3
Authority
PL
Poland
Prior art keywords
candida
veterinary
prophylaxis
therapy
ccm
Prior art date
Application number
PL05786111T
Other languages
English (en)
Inventor
Dagmar Braun
Vladimir Vrzal
Libor Bittner
Dagmar Koukalova
Original Assignee
Bioveta Ag
Vladimir Vrzal
Libor Bittner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioveta Ag, Vladimir Vrzal, Libor Bittner filed Critical Bioveta Ag
Publication of PL1791601T3 publication Critical patent/PL1791601T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL05786111T 2004-09-24 2005-09-23 Nowa szczepionka przeciwgrzybicza i sposób jej wytwarzania PL1791601T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004046391A DE102004046391A1 (de) 2004-09-24 2004-09-24 Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie
PCT/EP2005/010347 WO2006032533A1 (de) 2004-09-24 2005-09-23 Neuer impfstoff für veterinäre und humanmedizinische prophylaxe und therapie
EP05786111A EP1791601B1 (de) 2004-09-24 2005-09-23 Neuer impfstoff für veterinäre und humanmedizinische prophylaxe und therapie

Publications (1)

Publication Number Publication Date
PL1791601T3 true PL1791601T3 (pl) 2011-07-29

Family

ID=35453456

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05786111T PL1791601T3 (pl) 2004-09-24 2005-09-23 Nowa szczepionka przeciwgrzybicza i sposób jej wytwarzania

Country Status (13)

Country Link
US (1) US7648698B2 (pl)
EP (1) EP1791601B1 (pl)
JP (1) JP2008514568A (pl)
CN (1) CN101084042A (pl)
AT (1) ATE489997T1 (pl)
AU (1) AU2005287473A1 (pl)
BR (1) BRPI0515559A (pl)
CA (1) CA2579787A1 (pl)
DE (2) DE102004046391A1 (pl)
MX (1) MX2007003164A (pl)
PL (1) PL1791601T3 (pl)
RU (1) RU2007115160A (pl)
WO (1) WO2006032533A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2184997A4 (en) * 2007-07-31 2010-11-03 Univ New York DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
UA125386C2 (uk) * 2018-12-27 2022-03-02 Ігор Семенович Марков Інактивована рідка вакцина проти кандидозу, спосіб її отримання та спосіб лікування і профілактики нею
US11273190B2 (en) 2019-05-06 2022-03-15 Kenda Rigdon Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE3817762A1 (de) * 1988-05-26 1989-11-30 Sanum Kehlbeck Gmbh & Co Kg Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben
CS277558B6 (cs) 1991-11-28 1993-02-17 Lekarska Fakulta Up Vakcina k léčbě vleklých kvasinkových zánětů pochvy
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GB9801870D0 (en) * 1998-01-28 1998-03-25 Raby Limited Vaccine composition
KR100407128B1 (ko) 2000-10-20 2003-11-28 주식회사 바이오리 송화가루 또는 송화가루 추출물을 함유하는 피부외용제
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition

Also Published As

Publication number Publication date
US20080254068A1 (en) 2008-10-16
JP2008514568A (ja) 2008-05-08
MX2007003164A (es) 2007-10-23
ATE489997T1 (de) 2010-12-15
AU2005287473A1 (en) 2006-03-30
RU2007115160A (ru) 2009-01-20
EP1791601A1 (de) 2007-06-06
DE102004046391A1 (de) 2006-04-06
CA2579787A1 (en) 2006-03-30
WO2006032533A1 (de) 2006-03-30
DE502005010631D1 (de) 2011-01-13
EP1791601B1 (de) 2010-12-01
CN101084042A (zh) 2007-12-05
BRPI0515559A (pt) 2008-07-29
US7648698B2 (en) 2010-01-19

Similar Documents

Publication Publication Date Title
WO2009039980A3 (en) Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
WO2009043504A3 (en) Use of apelin-36 and optionally beta-melanotropin as therapeutic agents, eg for treating aids or alzheimer
WO2009033799A3 (en) Use of a peptide as a therapeutic agent
WO2009043478A3 (en) Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
WO2009033782A3 (en) Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
WO2009033733A3 (en) Use of apeptide as a therapeutic agent
WO2009033796A8 (en) Use of a peptide as a therapeutic agent
WO2009043507A3 (en) Use of a peptide as a therapeutic agent
WO2009033667A3 (en) Use of a peptide as a therapeutic agent
WO2009046832A3 (en) Short peptides used in medicine
WO2009033765A3 (en) Use of a peptide as a therapeutic agent
WO2009033741A3 (en) Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
WO2009033714A3 (en) Use of a peptide as a therapeutic agent
WO2009040073A3 (en) Use of a peptide as a therapeutic agent
WO2009033769A3 (en) Use of cortistatin 14 and others as a therapeutic agent
WO2009040085A3 (en) Use of exendin-4 and optionally salusin-alpha as therapeutic agent(s)
PL1791601T3 (pl) Nowa szczepionka przeciwgrzybicza i sposób jej wytwarzania
WO2009033788A3 (en) Use of a jck-301, optionally in combination with big endothelin, as a therapeutic agent.
WO2009040047A3 (en) Therapeutic uses of ghrelin and combinations with stresscopin
WO2009033729A3 (en) Therapeutic uses of gastrin- 1 and g- pen-grgdspca